Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15976 | TPP | 1/1 | 3 years ago 02 March 2023 23:52:50 UTC | View, Job request 15976 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15974 | TPP | 1/1 | 3 years ago 02 March 2023 23:38:31 UTC | View, Job request 15974 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15972 | TPP | 1/2 | 3 years ago 02 March 2023 23:31:37 UTC | View, Job request 15972 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15968 | TPP | 1/1 | 3 years ago 02 March 2023 22:40:24 UTC | View, Job request 15968 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15966 | TPP | 0/1 | 3 years ago 02 March 2023 22:37:05 UTC | View, Job request 15966 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15528 | TPP | 1/1 | 3 years ago 18 February 2023 21:44:30 UTC | View, Job request 15528 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14912 | TPP | 1/1 | 3 years, 1 month ago 03 February 2023 09:02:16 UTC | View, Job request 14912 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14542 | TPP | 1/1 | 3 years, 1 month ago 20 January 2023 03:46:25 UTC | View, Job request 14542 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14541 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 03:32:52 UTC | View, Job request 14541 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14540 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 03:24:08 UTC | View, Job request 14540 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14539 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 03:17:06 UTC | View, Job request 14539 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14538 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 03:07:58 UTC | View, Job request 14538 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14537 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 02:54:53 UTC | View, Job request 14537 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 14536 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 01:15:59 UTC | View, Job request 14536 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 14534 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 00:54:11 UTC | View, Job request 14534 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 14533 | TPP | 0/1 | 3 years, 1 month ago 20 January 2023 00:50:42 UTC | View, Job request 14533 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14532 | TPP | 1/1 | 3 years, 1 month ago 20 January 2023 00:11:06 UTC | View, Job request 14532 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14531 | TPP | 0/1 | - | View, Job request 14531 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14528 | TPP | 1/1 | 3 years, 1 month ago 19 January 2023 23:07:53 UTC | View, Job request 14528 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 14527 | TPP | 1/1 | 3 years, 1 month ago 19 January 2023 22:25:07 UTC | View, Job request 14527 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14523 | TPP | 1/1 | 3 years, 1 month ago 19 January 2023 18:26:51 UTC | View, Job request 14523 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14522 | TPP | 0/1 | 3 years, 1 month ago 19 January 2023 17:56:20 UTC | View, Job request 14522 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14521 | TPP | 0/1 | 3 years, 1 month ago 19 January 2023 17:47:55 UTC | View, Job request 14521 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14518 | TPP | 0/1 | 3 years, 1 month ago 19 January 2023 16:42:34 UTC | View, Job request 14518 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14476 | TPP | 1/1 | 3 years, 1 month ago 18 January 2023 09:48:14 UTC | View, Job request 14476 |